A so-called implantable insulin delivery device could one day free people with type 1 diabetes from the need for multiple daily injections, scientists say. "Diabetes is a difficult-to-treat condition, and yet keeping in very good balance ...
Omeros Corporation (NASDAQ: OMER) today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic ...
Teva Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its supplemental new drug application (sNDA) for three-times-a-week COPAXONE 40mg/mL, a new dose of COPAXONE. COPAXONE (glatiramer acetate ...
The EU Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve Roche's MabThera (rituximab) 1400mg solution for subcutaneous (SC) injection for the treatment of patients with common forms ...
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on FINOX Biotech's marketing authorisation application (MAA) for BEMFOLA (follitropin alfa solution for injection in ...
Etoposide plus cisplatin, given alongside accelerated hyperfractionated thoracic radiotherapy (AHTRT), remains the gold standard regimen for patients with limited-stage small-cell lung cancer (SCLC), Japanese researchers say. The phase ...
Even with a heavy dose of snow, ice and freezing temperatures early in the new year, the hay trade in Oklahoma remains extremely sluggish. That’s the observation of Jack Carson, market reporter for the Oklahoma Department of ...
The Beat the Q app allows consumers to order takeaway coffee ahead of time A new Australian phone app that allows users to order and pay for coffee en-route to their regular cafe — to ‘Beat the Q’ — has been ...
Tags: app, order takeaway coffee
Novo Nordisk, a world leader in diabetes care, today announced the launch of the insulin delivery device NovoPen Echo® in the United States. This is the first and only pen device available in the U.S. with half-unit dosing and a memory ...
Bayer HealthCare has failed to win the backing of the US FDA's Cardiovascular and Renal Drugs Advisory Committee to expand the use of its oral anticoagulant Xarelto (rivaroxaban) 2.5 mg twice daily (BID) in combination with standard ...
Tags: FDA Panel, ACS Patients
Humans cannot hope to survive life on Mars without plenty of protection from the surface radiation, freezing night temperatures and dust storms on the red planet. So they could be excused for marveling at humble Antarctic lichen that has ...
Tags: Lichen on Mars, Lichen
WASHINGTON, Jan. 15 (UPI) -- The U.S. Food and Drug Administration recommends health professionals discontinue prescribing combination drug products containing acetaminophen. The FDA recommends healthcare professionals discontinue ...
Tags: FDA, OTC, acetaminophen, acetaminophen-containing product
US-based medical device company Varian Medical Systems has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its updated ProBeam proton therapy system. Using the ProBeam system, clinicians can deliver the dose ...
Tags: Varian Medical, IMPT, ProBeam system
Like "Turn out the lights" and "Don't slam the door," being told to "Wash your hands" is one of those universal instructions children hear every day. But it's more than that. Hand washing has been shown to be one of the most effective ...
Tags: Health, Medicine, Washing Your Hands
Mallinckrodt (NYSE: MNK) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for PENNSAID® (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal ...